1 year return (CAGR)
633.45%
Attovia Therapeutics, Inc. Common Stock Exchange (NASDAQ, USD)
ATTO
20.83
-0.47 (-2.21%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
34.72%
5 year return (CAGR)
-7.26%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
950.92M
Price/Sales
-
Ent value
920.99M
Price/Book
7.17
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 21.31 |
| Daily high | 21.73 |
| Daily low | 19.86 |
| Daily Volume | 318K |
| All-time high | 25.55 |
| 1y analyst estimate | 42.20 |
| Beta | - |
| EPS (TTM) | -0.88 |
| Dividend per share | 0.00 |
| Ex-div date | 9 Nov 2017 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ATTO | S&P500 | |
| Current price drop from All-time high | -18.47% | -0.58% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 3 Aug 2023 | 9 Mar 2009 |
| Avg drop from high | -57.12% | -10.68% |
| Avg time to new high | 88 days | 12 days |
| Max time to new high | 2071 days | 1805 days |
News
